ZoomInfo
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 10 months.
- Recent price momentum is -49.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 11.3% of float.
- Analyst tilt is Hold.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation A+
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 5.5x | Better than 96% |
| Price / Sales | 0.8x | Better than 83% |
Growth B
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 4.4% | Better than 44% |
| Net income CAGR (3Y) | 25.3% | Better than 77% |
| Free cash flow CAGR (3Y) | 0.1% | Better than 39% |
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 84.0% | Better than 93% |
| Operating margin | 18.1% | Better than 72% |
| Net margin | 9.9% | Better than 59% |
| Return on equity | 7.8% | Better than 44% |
| Return on invested capital | 4.9% | Better than 45% |
Momentum D-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -30.5% | Better than 18% |
| 6-month return | -23.5% | Better than 24% |
| 12-month return (ex latest month) | -54.1% | Better than 2% |
| Distance below 52-week high | 74.3% | Better than 4% |
Financial Health B-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 0.7x | Better than 8% |
| Debt to assets | 24.4% | Better than 49% |
| Interest coverage | 5.6x | Better than 59% |
| Free cash flow / net income | 313.0% | Better than 86% |
Analyst View B-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 18.2% | Better than 9% |
| Upside to average target | 93.8% | Better than 82% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 2.83
- Open
- 2.80
- Day range
- 2.75 - 3.01
- Avg price
- 2.82
- Volume
- 5.36M
- Turnover
- 15.11M
- Turnover ratei
- 2.05%
- Volume ratioi
- 1.25
- Amplitudei
- 9.36%
- 52-week rangei
- 2.54 - 10.76
Valuation
- P/Ei
- 7.26
- P/E (TTM)i
- -1.41
- P/Bi
- 0.95
- EPSi
- 0.38
- Book value / shi
- 2.91
- Net profit
- 111.51M
- Net assets
- 852.74M
Share structure
- Market cap
- 809.90M
- Float capi
- 722.20M
- Shares out
- 293.44M
- Float sharesi
- 261.67M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-06-04
74.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-4.00M net over the window
Short interest
- Shares short
- 32.91M
- % of floati
- 11.30%
- Days to coveri
- 7.15
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of ZoomInfo (GTM)?
ZoomInfo last traded at 2.76. This page shows a periodic quote snapshot. Check the displayed quote time.
What is ZoomInfo's market cap?
About 809.90M.
What is the P/E ratio of ZoomInfo?
The trailing twelve-month P/E is -1.41, below its own 5-year average of 228.37 — toward the bottom of its historical range (6.60% percentile). See the Valuation tab for the full history.
Does ZoomInfo pay a dividend?
ZoomInfo does not currently pay a regular dividend.
Is ZoomInfo a buy according to analysts?
The consensus of 11 analysts is a Hold rating, with an average 12-month price target of 5.35, which implies 93.8% upside from the current price. This is not investment advice.
What is ZoomInfo's StockVane Quant Rating?
The StockVane Momentum strategy currently rates ZoomInfo a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-11-20 19:46:42 · For reference only, not investment advice and not tailored to your situation.
ZoomInfo discussion 0 comments